Related Experiment Video
Updated: May 3, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Gut barrier integrity disruption in atopic dermatitis: truth or myth-a case-control study
Naglaa M El Sayed1, Merna A Riad1, Raghda S Z Taleb2
1Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
This study found no significant differences in gut integrity markers between atopic dermatitis patients and controls. Further research is needed to explore the gut-skin axis in atopic dermatitis.
Area of Science:
- Gastroenterology
- Dermatology
- Immunology
Background:
- Gut dysbiosis is linked to atopic dermatitis (AD) by compromising intestinal barrier integrity.
- This disruption allows microbial translocation, triggering systemic immune responses.
Purpose of the Study:
- To investigate serum levels of gut integrity markers, claudin 3 and intestinal fatty acid-binding protein (I-FABP), in AD patients.
- To assess the relationship between these markers and clinical parameters in AD.
Main Methods:
- A prospective study involving 43 AD patients and 35 healthy controls.
- Serum levels of claudin 3 and I-FABP were quantified using enzyme-linked immunosorbent assays.
Main Results:
- No significant differences in serum claudin 3 or I-FABP levels were observed between AD patients and controls (P = 0.61 and 0.81, respectively).
- No significant correlations were found between these markers and clinical/laboratory parameters in AD.
Conclusions:
- The study suggests that intestinal barrier alterations may not be evident in this specific AD population.
- Further research is warranted to identify other gut-skin axis biomarkers and mechanisms in atopic dermatitis pathogenesis.
More Related Videos
09:32Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
07:32An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance
Published on: December 3, 2020
Related Concept Videos
The Skin Microbiota
Microbiome of the Eye
Gut-Brain Axis
Acne Infection
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease